Renbing Jia

6.9k total citations · 3 hit papers
174 papers, 4.4k citations indexed

About

Renbing Jia is a scholar working on Ophthalmology, Molecular Biology and Oncology. According to data from OpenAlex, Renbing Jia has authored 174 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Ophthalmology, 72 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Renbing Jia's work include Ocular Oncology and Treatments (62 papers), Nonmelanoma Skin Cancer Studies (16 papers) and Cancer-related molecular mechanisms research (15 papers). Renbing Jia is often cited by papers focused on Ocular Oncology and Treatments (62 papers), Nonmelanoma Skin Cancer Studies (16 papers) and Cancer-related molecular mechanisms research (15 papers). Renbing Jia collaborates with scholars based in China, United States and Germany. Renbing Jia's co-authors include Shengfang Ge, Xianqun Fan, Peiwei Chai, Zhi Yang, Qingfeng Shang, Yongyun Li, Ruobing Jia, Shaoyun Wang, Jie Yang and Hanhan Shi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Renbing Jia

163 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uveal melanoma

2020 495 citations Renbing Jia et al. profile →
The novel roles of circRNAs in human cancer

2019 393 citations Zhi Yang, Renbing Jia et al. Molecular Cancer profile →
Lactate and lactylation in cancer

2025 116 citations Ziyue Huang, Peiwei Chai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renbing Jia China	35	2.5k	1.4k	1.0k	950	558	174	4.4k
Jaume Mora Spain	36	3.1k 1.2×	1.0k 0.7×	354 0.3×	1.2k 1.3×	394 0.7×	216	5.5k
Klaus Griewank Germany	28	2.0k 0.8×	480 0.3×	1.4k 1.3×	2.5k 2.6×	1.7k 3.1×	82	5.3k
Armando Bartolazzi Italy	35	2.0k 0.8×	460 0.3×	220 0.2×	1.1k 1.1×	974 1.7×	115	4.1k
Ming Guan China	37	2.0k 0.8×	980 0.7×	118 0.1×	529 0.6×	486 0.9×	189	4.0k
Ángel M. Carcaboso Spain	33	1.4k 0.6×	299 0.2×	443 0.4×	645 0.7×	246 0.4×	100	3.1k
Mohamed H. Abdel‐Rahman United States	24	943 0.4×	266 0.2×	983 1.0×	637 0.7×	406 0.7×	81	2.4k
John M. Herndon United States	26	1.2k 0.5×	353 0.2×	374 0.4×	1.5k 1.6×	2.6k 4.7×	44	4.2k
Kishore K. Wary United States	31	2.8k 1.1×	842 0.6×	96 0.1×	547 0.6×	718 1.3×	66	4.9k
Rafael Fridman United States	31	2.5k 1.0×	2.4k 1.6×	140 0.1×	1.8k 1.9×	573 1.0×	52	5.5k
Takayuki Hattori Japan	40	2.9k 1.2×	197 0.1×	803 0.8×	1.2k 1.2×	241 0.4×	133	5.1k

Countries citing papers authored by Renbing Jia

Since Specialization

Citations

This map shows the geographic impact of Renbing Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renbing Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renbing Jia more than expected).

Fields of papers citing papers by Renbing Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renbing Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renbing Jia. The network helps show where Renbing Jia may publish in the future.

Co-authorship network of co-authors of Renbing Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Renbing Jia. A scholar is included among the top collaborators of Renbing Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renbing Jia. Renbing Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ge, Shengfang, Ti‐Fei Yuan, Xianting Ding, et al.. (2025). Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. Biomarker Research. 13(1). 125–125.

Huang, Ziyue, Jie Chen, Tianyu Zhu, et al.. (2025). Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications. Molecular Cancer. 25(1). 19–19.

Hu, Jianping, et al.. (2025). Association of Intratumoral Microbiota with Prognosis in Patients with Lacrimal Gland Tumor. Biomedicines. 13(4). 960–960.

Yu, Jie, Xiaoyu He, Shengfang Ge, et al.. (2024). The dual role of cellular senescence in human tumor progression and therapy. SHILAP Revista de lepidopterología. 5(9). e695–e695. 7 indexed citations

Wu, Haiyan, Xiaoqing Hu, Renbing Jia, et al.. (2024). Exploring the interplay between addiction and time perception: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 135. 111104–111104. 2 indexed citations

Zhang, Lingyu, Hui Pan, Yiran Yao, et al.. (2024). Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma. Asia-Pacific Journal of Ophthalmology. 13(5). 100108–100108.

Shi, Hanhan, Tianyu Zhu, Jie Chen, et al.. (2024). Genetic landscape and prognosis of conjunctival melanoma in Chinese patients. British Journal of Ophthalmology. 108(9). 1306–1312. 3 indexed citations

Fan, Jiayan, Xuyang Wen, Jie Yang, et al.. (2024). CACA guidelines for holistic integrative management of retinoblastoma. SHILAP Revista de lepidopterología. 3(1). 1 indexed citations

Shi, Hanhan, Jie Chen, Tianyu Zhu, et al.. (2024). Circulating Tumor DNA in Conjunctival Melanoma: Landscape and Surveillance Value. American Journal of Ophthalmology. 270. 67–76. 1 indexed citations

10.

Wei, Jinlian, Yongyun Li, Ruoxi Li, et al.. (2023). Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma. European Journal of Medicinal Chemistry. 250. 115238–115238. 4 indexed citations

11.

Shi, Hanhan, Xiaoyu He, Zhi Yang, et al.. (2023). The Use of rAAV2-RB1–Mediated Gene Therapy in Retinoblastoma. Investigative Ophthalmology & Visual Science. 64(15). 31–31. 3 indexed citations

12.

Zhuang, Ai, Xiang Gu, Tongxin Ge, et al.. (2023). Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m ⁶ A RNA methylation in ocular melanoma. Cancer Communications. 43(11). 1185–1206. 21 indexed citations

13.

Yao, Yiran, et al.. (2023). Adenomas of the ciliary body epithelium: clinics, histopathology and management. British Journal of Ophthalmology. 108(6). 826–832.

14.

Gu, Xiang, Ziyue Huang, Jie Chen, et al.. (2023). Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line. Investigative Ophthalmology & Visual Science. 64(15). 16–16. 1 indexed citations

15.

Ge, Tongxin, Xiang Gu, Renbing Jia, et al.. (2022). Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Communications. 42(11). 1049–1082. 114 indexed citations

16.

Shi, Jiahao, Tianyu Zhu, Min Zhou, et al.. (2022). Predicting the risk of distant and local recurrence for patients with ocular adnexal extranodal marginal zone lymphoma: a matched case–control study. British Journal of Ophthalmology. 107(10). 1560–1566. 3 indexed citations

17.

Wei, Jinlian, Xin Chen, Yongyun Li, et al.. (2022). Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78–FOXM1–KIF20A pathway. Acta Pharmaceutica Sinica B. 12(10). 3861–3876. 26 indexed citations

18.

Gu, Xiang, Jie Yu, Ludi Yang, et al.. (2022). Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. Journal of Pharmaceutical Analysis. 13(1). 24–38. 8 indexed citations

19.

Chai, Peiwei, Ruobing Jia, Yongyun Li, et al.. (2021). Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Progress in Retinal and Eye Research. 89. 101030–101030. 34 indexed citations

20.

Zhang, Leilei, Xiaolin Huang, Xiaowei Zhu, et al.. (2015). Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma. International Journal of Cancer. 138(6). 1442–1452. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact